These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25416534)

  • 1. Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional study.
    Arribas-Ibar E; Sánchez-Niubò A; Majó X; Domingo-Salvany A; Brugal MT
    Harm Reduct J; 2014 Nov; 11(1):33. PubMed ID: 25416534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdose prevention in injecting opioid users: the role of substance abuse treatment and training programs.
    Sarasa-Renedo A; Espelt A; Folch C; Vecino C; Majó X; Castellano Y; Casabona J; Brugal MT;
    Gac Sanit; 2014; 28(2):146-54. PubMed ID: 24418018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates.
    Barrio G; Bravo MJ; Brugal MT; Díez M; Regidor E; Belza MJ; de la Fuente L;
    Addiction; 2012 Jun; 107(6):1111-22. PubMed ID: 22151686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
    Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
    J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms.
    Toth EC; Tegner J; Lauridsen S; Kappel N
    Harm Reduct J; 2016 Oct; 13(1):27. PubMed ID: 27717366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London.
    Hickman M; Carnwath Z; Madden P; Farrell M; Rooney C; Ashcroft R; Judd A; Stimson G
    J Urban Health; 2003 Jun; 80(2):274-87. PubMed ID: 12791803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
    Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
    Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Alcohol and Opioid Use Among Harm Reduction Clients.
    Winstanley EL; Stover AN; Feinberg J
    Addict Behav; 2020 Jan; 100():106027. PubMed ID: 31683186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
    de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
    Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.
    Seal KH; Downing M; Kral AH; Singleton-Banks S; Hammond JP; Lorvick J; Ciccarone D; Edlin BR
    J Urban Health; 2003 Jun; 80(2):291-301. PubMed ID: 12791805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and implementation of an opioid overdose prevention program within a preexisting substance use disorders treatment center.
    Wilder CM; Brason FW; Clark AK; Galanter M; Walley AY; Winstanley EL
    J Addict Med; 2014; 8(3):164-9. PubMed ID: 24874760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
    Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
    Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration.
    Brugal MT; Barrio G; De LF; Regidor E; Royuela L; Suelves JM
    Addiction; 2002 Mar; 97(3):319-27. PubMed ID: 11964108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
    Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
    Ashford RD; Curtis B; Brown AM
    Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.
    Barrio G; De La Fuente L; Toro C; Brugal TM; Soriano V; Gonzalez F; Bravo MJ; Vallejo F; Silva TC;
    Epidemiol Infect; 2007 May; 135(4):592-603. PubMed ID: 17005071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.